UnknownNot Applicable

Time-In-Range Based Risk Stratification of Type 2 Diabetes Microvascular Complications

Singapore500 participantsStarted 2021-10-14

Plain-language summary

The goal of this observational study is to learn about the role of Time-in-Range to stratify the risk of micro vascular complications in adults with type 2 diabetes. The main questions it aims to answer are: 1. Is a lower Time-in-Range associated with a higher risk of diabetes microvascular complications, independent of HbA1c? 2. Is Time-in-Range lower among sulfonylurea and premixed insulin therapy users compared to non-sulfonylurea and non-premixed insulin therapy users, respectively.

Who can participate

Age range21 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type 2 diabetes, * Age \>= 21 years, * Ability to provide informed consent, * HbA1c done within 6 months of recruitment between 6-12% Exclusion Criteria: * Undergoing active chemotherapy or immunotherapy for cancer * Currently taking oral or injectable steroids * Chronic kidney disease on dialysis * Women who are pregnant or breastfeeding

What they're measuring

Presence of Diabetes Retinopathy

Timeframe: 10 years

Presence of Diabetes Neuropathy

Timeframe: 10 years

Presence of Diabetes Nephropathy

Timeframe: 10 years

Trial details

NCT IDNCT05787990

SponsorSingapore General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06

Contact for this trial

Suresh Rama Chandran, MD, MRCP(UK)

+6563264654 suresh.rama.chandran@singhealth.com.sg

View on ClinicalTrials.gov More Type 2 Diabetes trials